The [Het-s] Prion, an Amyloid Fold as a Cell Death Activation Trigger

Prions are self-propagating amyloids. Amyloids are proteinpolymers with a cross-b structure, in which short b-strands fromthe monomers stack one on top of each other to make up a fibrillarpolymer [1,2]. These amyloids act as templates that convertmonomers to the amyloid polymerised state. Spontaneous orchaperone-assisted fragmentation of this amyloid fibril allowsmultiplication of the prion particle by generating novel fibril endswhere templating occurs.Prions have initially been identified in the context of mamma-lian spongiform encephalopathies such as scrapie in sheep,Creutzfeld-Jacob disease in humans, or bovine spongiformencephalopathy (BSE) in cattle [3]. In these diseases, the hostencoded GPI-anchored PrP prion protein turns into prionaggregates, leading to incurable lethal neurodegenerative diseases.The prion phenomenon is not restricted to this sole example. Inparticular, nine prion proteins have been identified in yeast andcorrespond to proteins with a wide range of cellular functions [4].Generally, prion formation leads to loss of the cellular function ofthe protein. Yeast prions are thus detected as non-Mendeliangenetic elements, leading to infectious and inheritable proteininactivation.More than 30 human diseases, including Alzheimer disease, arecaused by accumulation of amyloid aggregates of various proteinsand peptides in the brain or systemic locations [2]. Many proteinscan form amyloids, and the amyloid fold has been envisioned as adefault conformational state that is formed when the native state ofthe protein cannot be efficiently attained or maintained. This viewis, for instance, illustrated by the finding that inclusion bodiesformed during recombinant protein over-expression in E. coli havean amyloid-like structure [5]. But in nature, the amyloid fold is notonly found in abnormal or pathological situations. The specificphysico-chemical properties of this fold have also been exploited toperform various biological functions. Amyloids constitute variouscell surface structures in bacteria, fungi, and insects. Amyloidsallow storage and delayed release of various peptide hormones inmammals [6]. Then, it has been proposed that this ability of aprotein to exist under two states (a functional and a self-inactivating form) represents an epigenetic mechanism of generegulation [7]. In that perspective, yeast prions have beensuggested to represent a benefit [8], but this view remains debated[9].


The [Het-s] Prion Has a Role in Non-Self Recognition
[Het-s] is a prion of the filamentous fungus Podospora anserina and is involved in a non-self recognition process termed heterokaryon incompatibility [10]. In filamentous fungi, cell fusions between different strains occur spontaneously and lead to the formation of heterokaryons, containing nuclei from both fusion partners. Yet, almost invariably, these heterokaryotic cells undergo cell death soon after fusion. This rejection of non-self is due to genetic differences between the fusion partners at certain specific loci designated het loci. The biological significance of incompatibility is not fully understood. Incompatibility could serve to limit the cytoplasmic mixing between unlike individuals to restrict transmission of mycoviruses between strains or to prevent conspeficic parasitism of one nuclear type by another. It has also been proposed that incompatibility in fungi could represent an evolutionary by-product of pathogen-driven divergence in genes whose primary function lies in host defense against microbial pathogens [11]. In this view, het genes were identified because they cause rejection of conspecific non-self, but their original function lies in the recognition of heterospecific non-self, a situation analogous to the MHC complex in mammals.
Nine het loci have been identified in Podospora anserina and het-s, the gene encoding the [Het-s] prion is one of them. The het-s locus has two alternative incompatible alleles, het-s and het-S. When a hets strain fuses with a het-S strain, the fusion cell undergoes cell death. But this cell death reaction only occurs when the HET-s protein is in the prion conformation. In other words, [Het-s] prion-infected strains are incompatible with het-S, while prion-free strains (designated [Het-s*]) are compatible with het-S. The [Het-s] prion is transmitted from one strain to another after cell fusion and is transmitted from the maternal parent to the meiotic progeny [10].

The Structure of the HET-s Prion Forming Domain Is Well Defined and Conserved in Evolution
The HET-s prion protein contains two distinct domains: an Nterminal a-helical globular domain designated HeLo and the Cterminal prion forming domain (PFD), which is necessary and sufficient for prion propagation and amyloid formation [12,13]. This domain is natively unfolded in the soluble conformation of the protein.
The structure of the HET-s PFD in its prion conformation was solved by solid state NMR [14]. The PFD adopts a b-solenoid structure with two repeated motifs of 21 amino acids delimiting a triangular hydrophobic core. This structure is exceptionally well resolved and organised, in contrast to many other amyloid proteins, which often exist as a mixture of structural variants. A number of HET-s orthologs have been identified in other pezizomycotina fungi, and sequence comparisons and functional studies reveal a conservation of key residues, critical for formation of the b-solenoid fold, and indicate a selective pressure for the maintenance of the ability to form that specific amyloid fold [15,16].

HET-s Is the Trigger for Activation of the HET-S Toxicity Domain
The HET-s and HET-S proteins differ by 13 residues, and the HET-S protein displays the same two-domain organisation as HET-s. The HET-s and HET-S PFD regions are functionally equivalent and interchangeable; the functional difference between HET-s and HET-S is determined by the amino acid differences in their HeLo domains [12]. The HeLo domain of HET-S represents the cell death execution domain in the het-s/het-S system. It is proposed that in the incompatibility reaction, the prion form of HET-s interacts with the PFD region of HET-S, and the conversion of the HET-S PFD region into the b-solenoid fold induces a conformational change in the HeLo domain, leading to its activation and triggering of cell death by incompatibility (Figure 1) [13]. Upon interaction with [Het-s], HET-S relocates to the cell periphery and this cell periphery localisation correlates with cell death [17]. In contrast, the HeLo domain of HET-s does not exert any toxicity. Thus, in the incompatibility reaction, HETs and HET-S do not have equivalent roles, the HET-S HeLo domain represents the cell death execution entity, and the prion form of [Het-s] acts as a trigger for activation of this toxicity domain. Sequence analyses suggest that het-s-homologs in other fungal species are actually HET-S rather than HET-s homologs.

NWD2 as a Functional Partner of HET-S
Recently, a potential additional functional partner of HET-S was identified. A search for proteins displaying homology to the HET-s PFD led to the identification of a protein termed NWD2 encoded by the gene immediately adjacent to het-S [18]. NWD2 is part of an NWD gene family comprising other het genes. NWD proteins are STAND proteins resembling Nod-like receptors and are thought to represent the fungal counterparts of pathogen recognition receptors described in plants and metazoans [19]. STAND proteins are signal transducing NTPases that undergo ligand-induced oligomerisation. They typically display three domains: a central nucleotide-binding oligomerisation domain (NOD) flanked by a C-terminal ligand-binding domain and an Nterminal effector domain. NWD2 lacks a defined effector domain and in its place displays at the N-terminal end a short region of homology with the elementary HET-s repeat motif [18]. Based on homology modelling, this region is predicted to adopt the bsolenoid fold. A model postulating the existence of a functional interaction between NWD2 and HET-S was proposed [18]. In that model, NWD2 recognises a ligand via its C-terminal WD-40 repeat domain and oligomerises in response to this binding. This oligomerisation step would put the N-terminal extensions of NWD2 proteins into close proximity and allow their cooperative folding into the b-solenoid fold. Once formed, this fold would be used as a template for transconformation of the HET-S PFD and activation of the HeLo toxicity domain. Thus, two modes of activation of the HET-S HeLo domain are now envisioned, either by interaction with the prion form of HET-s (as occurs during incompatibility) or by interaction with the oligomeric form of NWD2 (Figure 1).
This model postulates the existence of a mechanism of signal transduction STAND proteins where oligomerisation of a STAND protein induces formation of an amyloid-like fold in a short region N-terminal to the NOD domain. This amyloid-fold would in turn trigger transconformation of the protein responsible for the execution of the cell death reaction. Fungal genome analyses suggest that this mode of interaction between STAND signal transducing proteins and prion or prion-like proteins is not an isolated occurrence [18]. Several other analogous systems were identified in genome searches, suggesting that this mode of activation of effector domains is both widespread and evolutionarily conserved in fungi. What is emerging is the notion that transmission of an amyloid fold can be used as integrated part of a signal transduction pathway.
In the end, the focus needs to be redirected from [Het-s] to HET-S. [Het-s] turns out to be but a trigger to activate the HeLo toxicity domain of HET-S. HET-S is actually doing the job and represents the central player in the system. It will be of interest to elucidate the actual mechanism of toxicity that is associated with relocalisation of HET-S to the cell membrane. Other current questions regarding this system deal with the biological meaning of NWD2/HET-S pathway: what is the ligand recognised by NWD2, and what is the purpose of the HET-S-induced cell death reaction in response to this ligand binding?